Work

Dose‐range and dose‐frequency study of recombinant human interleukin‐1 receptor antagonist in patients with rheumatoid arthritis

Year: 1996

Type: article

Study design: Clinical Trial

Source: Arthritis & Rheumatism

DOI: 10.1002/art.1780390704

Authors: G. V. Campion, M. E. Lebsack, J. Lookabaugh, G. Gordon, M Catalano

Institution: Amgen (United States)

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998253405

FWCI: 17.71

Cites: 25

Cited by: 246

Related to: 9